Aquesta Financial Holdings, Inc.

Aquesta Financial Holdings, Inc. (AQFH) relating to its proposed acquisition by United Community Banks, Inc. Under the terms of the agreement, AQFH shareholders will receive 0.6386 shares of United per share they own.

QTS Realty Trust

QTS Realty Trust (QTS) relating to its proposed acquisition by Blackstone Group. Under the terms of the agreement, QTS shareholders will receive $78.00 in cash per share they own.

VPC Impact Acquisition Holdings III, Inc.

VPC Impact Acquisition Holdings III, Inc. (VPCC) relating to its proposed merger with Dave, a banking app. Under the terms of the agreement, VPCC will acquire Dave through a reverse-merger, with Dave emerging as a publicly traded company.

Live Oak Acquisition Corp. II

(LOKB) relating to its proposed merger with Navitas Semiconductor. Under the terms of the agreement, LOKB will acquire Navitas through a reverse-merger, with Navitas emerging as a publicly traded company.

Amplitude Healthcare Acquisition Corp.

Amplitude Healthcare Acquisition Corp. (AMHC) relating to its proposed merger with Jasper Therapeutics, Inc. Under the terms of the agreement, AMHC will acquire Jasper through a reverse-merger, with Jasper emerging as a publicly traded company.

U.S. Concrete, Inc

U.S. Concrete, Inc. (USCR) relating to its proposed acquisition by Vulcan Materials Co. (VMC) Under the terms of the agreement, USCR shareholders will receive $74.00 in cash per share they own.

Foresight Acquisition Corp.

Foresight Acquisition Corp. (FORE) relating to its proposed merger with P3 Health Partners. Under the terms of the agreement, FORE will acquire P3 through a reverse-merger, with P3 emerging as a publicly traded company.

Bowl America, Inc.

Bowl America, Inc. (BWL-A) relating to its proposed acquisition Bowlero Corp. Under the terms of the agreement, BWL-A shareholders will receive $8.53 in cash per share they own.

Cloudera, Inc.

Cloudera, Inc. (CLDR) relating to its proposed acquisition by affiliates of Clayton, Dubilier & Rice, LLC and Kohlberg Kravis Roberts & Co. L.P. Under the terms of the agreement, CLDR shareholders will receive $16.00 in cash per share they own.

Constellation Pharmaceuticals, Inc.

Constellation Pharmaceuticals, Inc. (CNST) relating to its proposed acquisition by MorphoSys AG (MOR). Under the terms of the agreement, CNST shareholders will receive $34.00 in cash per share they own.